Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$770M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$580M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$391M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$322M |
| 5 |
UnitedHealth
UNH
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 3 |
RP
RealPage, Inc.
RP
|
+$316M |
| 4 |
Shopify
SHOP
|
+$312M |
| 5 |
Boeing
BA
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.82% |
| 2 | Healthcare | 7.16% |
| 3 | Financials | 5.78% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
CALL
Compugen
CGEN
$222M
| $1.42M | ﹤0.01% |
170,900
+120,900
| +242% | +$982K |
|
4277
Exicure
XCUR
$10.2M
| $1.41M | ﹤0.01% |
6,283
+5,912
| +1,594% | +$1.55M |
|
|
BCLI
4278
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.41M | ﹤0.01% |
+24,764
| New | +$1.32M |
|
4279
Community Trust Bancorp
CTBI
$1.42B
| $1.41M | ﹤0.01% |
34,949
+7,506
| +27% | +$329K |
|
4280
Automatic Data Processing
ADP
$106B
| $1.41M | ﹤0.01% |
7,098
-10,358
| -59% | -$2.01M |
|
4281
Weyco Group
WEYS
$372M
| $1.41M | ﹤0.01% |
62,884
+45,592
| +264% | +$977K |
|
4282
Universal Technical Institute
UTI
$2.16B
| $1.41M | ﹤0.01% |
216,709
+194,013
| +855% | +$1.15M |
|
4283
CALL
Alcon
ALC
$33.6B
| $1.41M | ﹤0.01% |
20,000
| – | – |
|
4284
Fox Class A
FOXA
$24.5B
| $1.4M | ﹤0.01% |
37,801
-250,662
| -87% | -$9.41M |
|
4285
Paymentus
PAY
$4.29B
| $1.4M | ﹤0.01% |
+39,528
| New | +$1.24M |
|
4286
Zentalis Pharmaceuticals
ZNTL
$337M
| $1.4M | ﹤0.01% |
26,368
-101,861
| -79% | -$5.46M |
|
4287
Coursera
COUR
$1.52B
| $1.4M | ﹤0.01% |
35,428
-283,120
| -89% | -$12.2M |
|
|
PRO
4288
DELISTED
PROS Holdings
PRO
| $1.4M | ﹤0.01% |
+30,766
| New | +$1.36M |
|
4289
Upbound Group
UPBD
$1.13B
| $1.4M | ﹤0.01% |
26,419
-206,453
| -89% | -$12M |
|
4290
International Bancshares
IBOC
$4.76B
| $1.4M | ﹤0.01% |
32,626
+20,081
| +160% | +$938K |
|
4291
CALL
Rocket Companies
RKT
$36.5B
| $1.4M | ﹤0.01% |
72,400
+36,200
| +100% | +$733K |
|
|
GBT
4292
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.4M | ﹤0.01% |
40,000
+30,000
| +300% | +$1.17M |
|
4293
FirstService
FSV
$6.48B
| $1.4M | ﹤0.01% |
8,177
-37,339
| -82% | -$6.13M |
|
4294
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $1.4M | ﹤0.01% |
14,700
-23,875
| -62% | -$2.25M |
|
4295
First Financial Bancorp
FFBC
$3.55B
| $1.4M | ﹤0.01% |
59,050
-101,766
| -63% | -$2.53M |
|
4296
iShares MSCI India ETF
INDA
$6.89B
| $1.4M | ﹤0.01% |
31,526
-55,740
| -64% | -$2.39M |
|
4297
Schwab US Large- Cap ETF
SCHX
$71.8B
| $1.4M | ﹤0.01% |
+80,484
| New | +$1.36M |
|
4298
Stock Yards Bancorp
SYBT
$2.64B
| $1.39M | ﹤0.01% |
27,391
+18,046
| +193% | +$932K |
|
|
BNFT
4299
DELISTED
Benefitfocus, Inc.
BNFT
| $1.39M | ﹤0.01% |
98,758
+79,905
| +424% | +$1.13M |
|
4300
PUT
Vornado Realty Trust
VNO
$7.41B
| $1.39M | ﹤0.01% |
29,800
| – | – |
|
Similar funds
Millennium Management's Q2 2021 Portfolio in Review
As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.
- Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
- Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
- Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
- Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
- Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
- Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.